Delivery Order SPE2DB22D3501-SPE2DB26FTL20
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 2 mg tablets (30-count units) valued at $9,670.51 with a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 25, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 22, 2025, for Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.83 to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. The delivery order, issued on October 27, 2025, with a completion date of November 18, 2025, represents a non-competitive, non-set-aside award to support federal pharmaceutical procurement needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30s, with a contract ceiling value of $5,701.68 and an ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Mekinist 2 mg tablets (30-count units) valued at $9,670.51 with a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the company's role in...
- The Defense Logistics Agency awarded a $40,764.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where the contractor maintains its...
- The Defense Logistics Agency awarded a $17,104.98 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 25, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,341.02 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTL20Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Mekinist 2 mg tablets in a quantity of 30 units, with a ceiling value of $9,670.50. This is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, designated as SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving defense and military healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a broad range of pharmaceutical products and medical supplies. Mekinist (trametinib) is an oncology medication used in cancer treatment, consistent with AmerisourceBergen's role in supplying specialized pharmaceutical commodities across multiple therapeutic domains to support military healthcare programs. The contract reflects the company's capability to fulfill federal medical supply requirements through competitive procurement processes and its established position as a prime pharmaceutical vendor for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 11/7/25 |